Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check4 days agoChange DetectedRevision history now includes Revision: v3.3.3, and entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new record revision v3.3.2 was added to the history, and the prior revision v3.2.0 was removed from the list.SummaryDifference0.1%

- Check39 days agoChange DetectedA government funding operating-status notice was removed from the page.SummaryDifference0.7%

- Check54 days agoChange DetectedNew version entries appear in the Record History, adding more submitted changes and showing updates to study status and locations.SummaryDifference0.1%

- Check82 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%

- Check90 days agoChange DetectedThe page now shows revision v3.1.0, replacing v3.0.2. This is a version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.